Cagrilintide

Product Description

Cagrilintide is a research-grade analog of the endogenous hormone amylin, which plays a crucial role in the regulation of appetite and energy homeostasis. This compound is primarily investigated for its potential applications in weight management and metabolic health, particularly in conjunction with GLP-1 receptor agonists to enhance therapeutic outcomes in obesity treatment.

Mechanism of Action

• Cagrilintide functions as a long-acting amylin receptor agonist, promoting satiety signaling, delaying gastric emptying, and consequently reducing food intake in various experimental models of obesity.
• Research indicates that cagrilintide may lead to significant improvements in body weight, waist circumference, and metabolic markers, both as a standalone treatment and when used alongside incretin-based therapies.

Research Applications

• This compound has been shown to facilitate dose-dependent weight loss primarily through mechanisms that reduce caloric intake rather than through thermogenic effects, making it a valuable tool for studying sustained appetite suppression.
• Experimental studies suggest that cagrilintide may also aid in controlling hedonic eating and reducing cravings, thereby supporting research into long-term adherence to calorie-restricted diets.

For research and laboratory use only. Not for human consumption.